Category: Chronic kidney disease

Sleep disturbances are highly prevalent among individuals with chronic kidney disease (CKD), affecting up to 50% of patients on dialysis. While non-pharmacological therapies are often the first approach, understanding what sleep medication is used for CKD patients is critical for effective management. Due to impaired kidney function, medication selection requires careful consideration to minimize adverse effects and prevent drug accumulation.

Mircera, an erythropoiesis-stimulating agent (ESA), was first approved by the FDA in 2007. The generic name for Mircera is methoxy polyethylene glycol-epoetin beta, a modified version of the naturally occurring hormone erythropoietin used to treat anemia associated with chronic kidney disease (CKD).

According to the European Medicines Agency (EMA), roxadustat is a first-in-class, orally administered medication for symptomatic anemia associated with chronic kidney disease (CKD), and it is also known by other names. This article answers the question, **what is another name for roxadustat?**, and provides context on this important drug.

Affecting millions of individuals with chronic kidney disease, anemia is a common and serious complication. What is the drug roxadustat used for is to address this very issue, functioning as an oral medication that stimulates red blood cell production by mimicking the body's natural response to low oxygen levels.

Chronic kidney disease affects an estimated 1 in 7 adults in the US, and managing its progression is crucial for quality of life. Nephrokit DS, which contains Alpha Ketoanalogue, is a medication used to help treat and manage chronic kidney disease, particularly alongside a low-protein diet. It serves as a nutritional supplement to support kidney health and delay the need for dialysis.